Winton Group’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
APM
N
TCM
SFM
Winton Group's ALT Position: Q4 2021 in Review
Winton Group sold out of Altimmune (ALT) in Q4 2021, closing a stake of 15,751 shares — an estimated $178K sold.
Winton Group first reported a position in ALT in Q3 2019 and held it in 7 quarters. The position peaked at $1.46M in Q2 2020. 102 funds tracked by Wall St. Rank hold ALT as of Q4 2021.
- Winton Group reported no remaining Altimmune position as of Q4 2021 after selling out during the quarter.
- Winton Group sold 15,751 Altimmune shares in Q4 2021, an estimated $178K.
- Winton Group first reported a position in Altimmune in Q3 2019 and held it in 7 quarters.
- Winton Group's Altimmune position peaked at $1.46M in Q2 2020.
- 102 funds tracked by Wall St. Rank held Altimmune as of Q4 2021.
Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.